SPONSOR
Ubix Therapeutics, Inc.
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Relapsed/Refractory B-cell Malignancies
Ubix Therapeutics, Inc. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Relapsed/Refractory B-cell Malignancies.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ubix Therapeutics, Inc.
How many clinical trials has Ubix Therapeutics, Inc. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Ubix Therapeutics, Inc., of which 1 are actively recruiting participants. These trials cover conditions including Relapsed/Refractory B-cell Malignancies. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ubix Therapeutics, Inc. research focus on?
Ubix Therapeutics, Inc. clinical trials span Relapsed/Refractory B-cell Malignancies. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ubix Therapeutics, Inc. clinical trial?
To participate in a Ubix Therapeutics, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ubix Therapeutics, Inc. trials with current recruitment status updated daily.
Clinical Trials by Ubix Therapeutics, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology